Trial
NCT01784159
ASpirin for Patients With SEPsis and SeptIc Shock
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Federal University of São Paulo
Collaborators
—
Condition
Sepsis
Intervention
Aspirin
Why stopped
Terminated: The study was stopped prematurely and will not be resumed due to the higher number of bleeding cases in the intervention group, as recomended by the Data Safety Monitoring Board on February 7, 2023.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-07-13